Advances in Hematology
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
- PublisherHindawi
- LanguageEnglish
- Article Processing ChargesUSD 800
- Publication Time15
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Website URL
- Other charges
- Plagiarism
- Publication Time15
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 20% |
| 4-6 | 47% |
| 7-9 | 13% |
| >9 | 20% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
What is the H-index. SNIP score, Citescore and SJR of Advances in Hematology? 
Advances in Hematology has a H-index score of 36, Citescore of 2.8, SNIP score of 0.95, & SJR of Q3
Who is the publisher of Advances in Hematology?
The publisher of Advances in Hematology is Hindawi.
How can I view the journal metrics of Advances in Hematology on editage?
For the Advances in Hematology metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Advances in Hematology?
The eISSN number is 1687-9112 and pISSN number is 1687-9104 for Advances in Hematology.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Thrombophilia, Hemoglobin, Vaso-occlusive crisis, Blood transfusion, Rivaroxaban, Melphalan, Recurrent thromboembolism, Median time, Nonsteroidal, Tramadol, Electrotherapy, Haploidentical Donor, Anemia, Apixaban, Warfarin, Fludarabine, Monoclonal gammopathy of undetermined significance.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.